The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
Open accessThe DOI matches its Crossref record; 131 of the 134 references it cites were found in a registry or an index.
Abstract
The development of culture-independent techniques for microbiological analysis has uncovered the previously unappreciated complexity of the bacterial microbiome at various anatomic sites. The microbiome of the lung has relatively less bacterial biomass when compared with the lower gastrointestinal tract yet displays considerable diversity. The composition of the lung microbiome is determined by elimination, immigration, and relative growth within its communities. Chronic lung disease alters these factors. Many forms of chronic lung disease demonstrate exacerbations that drive disease progression and are poorly understood. Mounting evidence supports ways in which microbiota dysbiosis can influence host defense and immunity, and in turn may contribute to disease exacerbations. Thus, the key to understanding the pathogenesis of chronic lung disease may reside in deciphering the complex interactions between the host, pathogen, and resident microbiota during stable disease and exacerbations. In this brief review we discuss new insights into these labyrinthine relationships.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, the lungs’ surface approximates 1 m2/kg of body weight and is not sterile (108).”
From The microbiome and human cancer (2021) · cites this paper as [108]
In the citing paper
“metabolites produced by the microbiota could have an important immunoregulatory function specifically targeting the IL-1 axis (590, 591).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [590]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., & Knight, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002601107 · Cited by 4,774
Grice, E. A., & Segre, J. A. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2537 · Cited by 3,143
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
Community study of role of viral infections in exacerbations of asthma in 9–11 year old children
Johnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Lampe, F., Josephs, L., Symington, P., Toole, S. O., Myint, S. H., Tyrrell, D. A. J., et al. (1995) · BMJ · doi:10.1136/bmj.310.6989.1225 · Cited by 1,991
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Cited by
Items 101–200 of 362
The respiratory microbiome in idiopathic pulmonary fibrosis
Hewitt, R. J., & Molyneaux, P. L. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.01.56 · Cited by 46
“Furthermore, these studies do not enlighten us to the interaction between each of the bacterial colonies which is likely to also be relevant (42).”
BackgroundLung Microbiome Participation in Local Immune Response Regulation in Respiratory Diseases
Lira-Lucio, J. A., Falfán‐Valencia, R., Ramírez‐Venegas, A., Buendía-Roldán, I., Rojas‐Serrano, J., Mejía, M. E., & Pérez-Rubio, G. (2020) · Microorganisms · doi:10.3390/microorganisms8071059 · Cited by 50
“In sarcoidosis, just a few years ago, Atopobium spp. and Fusobacterium spp. were identified in the highest abundance [72].”
BackgroundInfluentialPerinatal Nutritional and Metabolic Pathways: Early Origins of Chronic Lung Diseases
Kuiper-Makris, C., Selle, J., Nüsken, E., Dötsch, J., & Alcazar, M. A. A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.667315 · Cited by 47
“The lung microbiome has a strong influence on the susceptibility to a wide array of chronic lung diseases, including COPD, asthma, Idiopathic Pulmonary Fibrosis (IPF) as well as altering the prognosis of cystic fibrosis (CF) (274).”
BackgroundMyeloid-derived suppressor cells in non-neoplastic inflamed organs
Sendo, S., Saegusa, J., & Morinobu, A. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0076-7 · Cited by 41
Guler, S. A., Clarenbach, C., Brutsche, M. H., Hostettler, K., Brill, A.-K., Schertel, A., Geiser, T. K., & Funke-Chambour, M. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202103-266oc · Cited by 39
Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients
Boutin, S., & Dalpke, A. H. (2017) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-016-0067-1 · Cited by 45
“Furthermore, there is evidence that the success of antimicrobial therapy is impacted by microbemicrobe interactions, indicating that a personalized therapy which takes into account the individual microbiome should be favored [65].”
BackgroundThe Human Respiratory Microbiome: Implications and Impact
Mitchell, A. B., & Glanville, A. R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1617441 · Cited by 43
Bacterial extracellular electron transfer in plant and animal ecosystems
Stevens, E. T., & Marco, M. L. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad019 · Cited by 42
The evolving role of the lung microbiome in pulmonary fibrosis
Lipinski, J. H., Moore, B. B., & O’Dwyer, D. N. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00258.2020 · Cited by 37
Self-citationSmoking related environmental microbes affecting the pulmonary microbiome in Chinese population
Liu, X., Sun, W., Ma, W., Wang, H., Xu, K., Zhao, L., & He, Y. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.154652 · Cited by 37
Ali, N. A. B. M., Aogáin, M. M., Morales, R. F., Tiew, P. Y., & Chotirmall, S. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20204991 · Cited by 37
“[25] Indeed such taxa, though detectable by PCR, may not be viable.”
BackgroundDifferential flora in the microenvironment of lung tumor and paired adjacent normal tissues
Mao, Q., Ma, W., Wang, Z., Liang, Y., Zhang, T., Yang, Y., Xia, W., Jiang, F., Hu, J., & Xu, L. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa044 · Cited by 39
Margaroli, C., & Tirouvanziam, R. M. (2016) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-016-0066-2 · Cited by 41
Wong, L. M., Shende, N., Li, W. T., Castaneda, G., Apostol, L., Chang, E. Y., & Ongkeko, W. M. (2020) · Cancers · doi:10.3390/cancers12061447 · Cited by 41
“One study found over nine genera of bacteria in the lungs [5,6].”
BackgroundToraldo, D. M., & Conte, L. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3875 · Cited by 40
“This injury was induced by Th17 cells and IL-17 neutralization [53, 95].”
BackgroundOut-Smarting the Host: Bacteria Maneuvering the Immune Response to Favor Their Survival
Mues, N., & Chu, H. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00819 · Cited by 39
“In fact, human lungs are colonized with diverse bacteria including the genera Prevotella, Streptococcus, Klebsiella, Veillonella, Neisseria, Haemophilus, pseudomonas, and Fusobacterium (1, 2).”
BackgroundWillis, K. A., Stewart, J. D., & Ambalavanan, N. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00360.2020 · Cited by 40
Lipinksi, J. H., Ranjan, P., Dickson, R. P., & O’Dwyer, D. N. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300716 · Cited by 41
Self-citationDóra, D., Szőcs, E., Soós, Á., Halasy, V., Somodi, C., Mihucz, A., Rostás, M., Mógor, F., Lohinai, Z., & Nagy, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1434804 · Cited by 34
Sommerstein, R., Merz, T. M., Berger, S., Kraemer, J. G., Marschall, J., & Hilty, M. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0530-6 · Cited by 34
Hammad, D. B. M., Liyanapathirana, V. C., & Tonge, D. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225110 · Cited by 39
“Whilst the colonisation of specific body sites in contact with the external 85 environment (such as the gastrointestinal tract, skin and vagina) by microorganisms is 86 both well-described and universally accepted [3], the existence of microorganisms and 87 or microbial DNA in other “classically sterile” locations inc…”
BackgroundPathobiology of frailty in lung disease
Koons, B., Greenland, J. R., Diamond, J. M., & Singer, J. P. (2020) · Translational research · doi:10.1016/j.trsl.2020.04.001 · Cited by 36
Dawoodbhoy, F. M., Patel, B. K., Patel, K. H., Bhatia, M., Lee, C. N., & Moochhala, S. (2020) · Shock · doi:10.1097/shk.0000000000001654 · Cited by 39
The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases
Gonçalves, S. M., Lagrou, K., Duarte-Oliveira, C., Maertens, J. A., Cunha, C., & Carvalho, A. (2017) · Virulence · doi:10.1080/21505594.2016.1257458 · Cited by 32
“phyla: Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Fusobacteria and Cyanobacteria.(8) Despite such”
BackgroundCommunity-acquired pneumonia in chronic obstructive pulmonary disease
Cavallazzi, R., & Ramírez, J. A. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000639 · Cited by 34
Zhuo, M., An, T., Zhang, C., & Wang, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01584 · Cited by 34
“airway samples through routine microbiological methods (7).”
Chen, Z., Li, Z., Li, S., Guan, W., Qiu, Y., Lei, Z., Zhan, Y., Zhou, H., Lin, S., Wang, X., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06255-9 · Cited by 35
Pérez‐Cobas, A. E., Ginévra, C., Rusniok, C., Jarraud, S., & Buchrieser, C. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101167 · Cited by 33
Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease
O’Dwyer, D. N., Kim, J. S., Ma, S., Ranjan, P., Das, P., Lipinski, J. H., Metcalf, J. D., Falkowski, N. R., Yow, E. S., Anstrom, K. J., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202308-1357oc · Cited by 38
Self-citationInfluence of Microbiota on Tumor Immunotherapy
Yu, X., Li, W., Li, Z., Wu, Q., & Sun, S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91771 · Cited by 37
“The skin, which is the largest and outermost organ of the human body, plays a pivotal role in preserving host homeostasis by actively communicating with its resident microbiota, keratinocytes, and an array of skin immune components [221].”
BackgroundEpithelial Dysfunction in Lung Diseases: Effects of Amino Acids and Potential Mechanisms
Chen, J., Jin, Y., Yang, Y., Wu, Z., & Wu, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-45328-2_4 · Cited by 31
“This may be a reason why the intestinal microbiota affects the development of lung diseases as observed in clinical patients and experimental animals (O’Dwyer et al. 2016).”
BackgroundCrawford, M. S., Nordgren, T. M., & McCole, D. F. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00423.2020 · Cited by 37
“Although the exact mechanisms continue to be examined, studies have shown that gut bacteria interact with the mucosal immune system via metabolites, including proinflammatory and regulatory signals (22, 137, 153, 154).”
BackgroundRepertoire of Bacterial Species Cultured from the Human Oral Cavity and Respiratory Tract
Fonkou, M. D. M., Dufour, J.-C., Dubourg, G., & Raoult, D. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0181 · Cited by 33
Comparative analysis of the pulmonary microbiome in healthy and diseased pigs
Li, Z., Wang, X., Di, D., Pan, R., Gao, Y. L., Xiao, C., Li, B., Wei, J., Liu, K., Qiu, Y., et al. (2020) · Molecular Genetics and Genomics · doi:10.1007/s00438-020-01722-5 · Cited by 30
Translocation and Dissemination of Gut Bacteria after Severe Traumatic Brain Injury
Yang, W., Yuan, Q., Li, Z., Du, Z., Wu, G., Yu, J., & Hu, J. (2022) · Microorganisms · doi:10.3390/microorganisms10102082 · Cited by 31
“However, the existence of a healthy lung microbiota which includes Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria, is now widely accepted [26,27].”
BackgroundRao, M., Dodoo, E., Zumla, A. I., & Maeurer, M. J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00962 · Cited by 31
Microbiota, natural products, and human health: exploring interactions for therapeutic insights
Qadri, H., Shah, A. H., Almilaibary, A., & Mir, M. A. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1371312 · Cited by 32
“For instance, long-term lung conditions may change the lung microbiome ’ s makeup, which may then impact host immunity and defense and worsen the conditions (O ’ Dwyer et al., 2016).”
BackgroundEngineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination
McCright, J., & Maisel, K. (2019) · Tissue Barriers · doi:10.1080/21688370.2019.1695476 · Cited by 28
Tavárez, Z. Q., Li, D., Croft, D. P., Gill, S. R., Ossip, D. J., & Rahman, I. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.589501 · Cited by 31
“The respiratory tract harbors a low biomass, low diversity bacterial community that play an important role on maintaining lung homeostasis and as part of the local innate immune response (O’Dwyer et al., 2016).”
BackgroundTzani-Tzanopoulou, P., Skliros, D., Megremis, S., Xepapadaki, P. V., Andreakos, E., Чанішвілі, Н., Flemetakis, E., Kaltsas, G., Τaka, S., Lebessi, E., et al. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2020.617240 · Cited by 28
“The Microbiome in Asthma Healthy adults are breathing ∼7000L of air per day (50, 51) and their upper and lower airways are constantly exposed to a variety and large number of microorganisms.”
BackgroundAmat, S., Dahlen, C. R., Swanson, K. C., Ward, A. K. K., Reynolds, L. P., & Caton, J. S. S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.854453 · Cited by 36
Synodinou, K. D., Nikolaki, M. D., Τriantafyllou, Κ., & Kasti, A. N. (2022) · Microorganisms · doi:10.3390/microorganisms10091764 · Cited by 30
“In addition, changes in lung flora affect cytokine production by triggering the transition from anti-inflammatory to proinflammatory cytokines, thus promoting injury to the pulmonary epithelium resulting in fibrosis [4].”
BackgroundInfluentialKumar, A., Patel, V., Harding, J. N., You, D., & Cormier, S. A. (2021) · Particle and Fibre Toxicology · doi:10.1186/s12989-021-00438-7 · Cited by 29
“The lung resident microbiome, for example, is known to play a major role in tissue homeostasis and provides resistance against invading pathogens [59].”
BackgroundAmrouche, T., & Chikindas, M. L. (2022) · AIMS Microbiology · doi:10.3934/microbiol.2022024 · Cited by 28
“) and Bacteroidetes (Bacteroides) are being prevalent, and Proteobacteria (Escherichia) and Actinobacteria (Bifidobacterium) less abundant [81] whereas Bacteroidetes, Firmicutes, and Proteobacteria predominant among lung microbiota [79].”
BackgroundPharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options
Trachalaki, A., Irfan, M., & Wells, A. U. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1822326 · Cited by 26
Zheng, L., Liu, C., Wang, H., Zhang, J., Mao, L., Dong, X., Hu, S., Li, N., Pi, D., Qiu, J., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01772-6 · Cited by 32
Culturomics, a potential approach paving the way toward bacteriotherapy
Matar, G. M., & Bilen, M. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102194 · Cited by 31
The lung microbiota in nontuberculous mycobacterial pulmonary disease
Kim, B., Kang, N., Kim, S., Kim, D. H., Kim, H., Kwon, O. J., Huh, H. J., Lee, N. Y., & Jhun, B. W. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285143 · Cited by 26
“The microbiome, an ecological niche of microbial communities (e.g., bacteria, viruses, fungi, and archaea), has recently been reported to affect the clinical course and pathogenesis of respiratory diseases [8, 9].”
BackgroundPulmonary and intestinal microbiota dynamics during Gram-negative pneumonia-derived sepsis
Wolff, N. S., Jacobs, M. C., Wiersinga, W. J., & Hugenholtz, F. (2021) · Intensive Care Medicine Experimental · doi:10.1186/s40635-021-00398-4 · Cited by 25
“However, in (chronic) airway diseases, such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis, a shift occurs in this balance leading to changes in the microbiota [40, 41].”
BackgroundThe Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
Kim, S., Park, H. J., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416154 · Cited by 28
Li, W., Huang, Y., Tong, S., Wan, C., & Wang, Z. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116291 · Cited by 23
Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases
Shastri, M. D., Allam, V. S. R. R., Shukla, S. D., Jha, N. K., Paudel, K. R., Peterson, G. M., Patel, R. P., Hansbro, P. M., Chellappan, D. K., & Dua, K. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119871 · Cited by 23
Cheong, D., & Song, J. Y. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2429235 · Cited by 31
“88,89 Alveolar dysbiosis in COPD results in abnormal macrophage function and surfactant degradation.”
Hennig‐Pauka, I., Hartmann, M., Merkel, J., & Kreienbrock, L. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.802570 · Cited by 25
van Charante, F., Wieme, A. D., Rigole, P., Canck, E. D., Ostyn, L., Grassi, L. C., Deforce, D. L. D., Crabbé, A., Vandamme, P. A. R., Joossens, M., et al. (2022) · Biofilm · doi:10.1016/j.bioflm.2022.100079 · Cited by 21
“During an infection the lung microbiome is typically disturbed, and the prevalence of presumed commensals like Prevotella spp. decreases in favor of that of pathogenic bacteria [59 – 61].”
Host lung microbiota promotes malaria-associated acute respiratory distress syndrome
Mukherjee, D., Chora, Â. F., Lone, J., Ramiro, R. S., Blankenhaus, B., Serre, K., Ramirez, M., Gordo, I., Veldhoen, M., Varga‐Weisz, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31301-8 · Cited by 22
The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity
Huynh, M., Crane, M. J., & Jamieson, A. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1094110 · Cited by 25
“inhalation and immigration of microbes from the oral and tracheal cavities as well as from the environment, regular immune surveillance and respiratory clearance, and the local growth conditions, including but not limited to pH, temperature, oxygen availability, nutrient availability, growth dominance of other organis…”
BackgroundThe human microbiome: A promising target for lung cancer treatment
Sun, Y. H., Wen, M., Liu, Y., Wang, Y., Jing, P., Gu, Z., Jiang, T., & Wang, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1091165 · Cited by 30
“Last, Huang et al. found that the number of Veillonella,Megacoccus, Actinomyces and Arthrobacter was significantly higher in AC than in SCC.”
BackgroundInfluentialBenchmarking MicrobIEM – a user-friendly tool for decontamination of microbiome sequencing data
Hülpüsch, C., Rauer, L., Nußbaumer, T., Schwierzeck, V., Bhattacharyya, M., Erhart, V., Traidl‐Hoffmann, C., Reiger, M., & Neumann, A. U. (2023) · BMC Biology · doi:10.1186/s12915-023-01737-5 · Cited by 25
Shi, J., Xiao, Y., Zhang, Y., Geng, D., Cong, D., Shi, K. X., & Knapp, R. J. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14629 · Cited by 23
Lung Microbiome in Human Health and Diseases
Chauhan, N. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00077-2 · Cited by 26
Guler, S. A., Clarenbach, C. F., Brutsche, M. H., Hostettler, K., Brill, A., Schertel, A., Geiser, T., & Funke-Chambour, M. (2021) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-211858 · Cited by 19
Marinho, Y., Villarreal, E. S., Aboagye, S. Y., Williams, D. L., Sun, J., Silva, C. L. M., Lutz, S. E., & Oliveira, S. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1254762 · Cited by 18
“Recent fi ndings indicate that similar to the gut, the lungs are populated by a diverse microbiota (5), but it was unclear whether its disruption (i.e., dysbiosis) also contributed to the development of PAH.”
BackgroundDetecting respiratory bacterial communities of wild dolphins: implications for animal health
Nelson, T., Wallen, M. M., Bunce, M., Oskam, C. L., Lima, N., Clayton, L., & Mann, J. (2019) · Marine Ecology Progress Series · doi:10.3354/meps13055 · Cited by 24
“…written consent of the publisher Mar Ecol Prog Ser 622: 203–217, 2019 on the lung microbiome in humans and model animal species, such as the mouse, indicate that this community is important in the pathogenesis of disease and regulation of immune functions (O’Dwyer et al. 2016, Shukla et al. 2017).”
BackgroundPerspectives in lung microbiome research
Sulaiman, I., Schuster, S., & Segal, L. N. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.06.001 · Cited by 19
“Additionally, we now know that the gut microbiome modulates the systemic immune tone contributing to the differentiation of IL17 producing T cells and regulatory T cells [2], whereas the lung microbiome field has so far only show associations between lung microbiota signatures and host immune phenotype [3-5].”
BackgroundYanuck, S. F., Pizzorno, J. E., Messier, H., & Fitzgerald, K. N. (2020) · PubMed Central · Cited by 24
Identification of Lung and Blood Microbiota Implicated in COVID-19 Prognosis
Dereschuk, K. J., Apostol, L., Ranjan, I., Chakladar, J., Li, W. T., Rajasekaran, M. R., Chang, E. Y., & Ongkeko, W. M. (2021) · Cells · doi:10.3390/cells10061452 · Cited by 18
“As shown in a previous study, “shifts in cytokine profiles mediated by changes in the microbiota may also promote epithelial injury and fibrotic outcomes” in chronic lung disease and in COVID-19, and similar associations were observed in our study [24,25].”
ResultOliveira, S. D. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316236 · Cited by 21
Fastrès, A., Roels, É., Vangrinsven, E., Taminiau, B., Jabri, H., Bolen, G., Merveille, A., Tutunaru, A.-C., Moyse, E. V., Daube, G., et al. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01784-w · Cited by 21
The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
Ntolios, P., Tzilas, V., Bouros, E., Avdoula, E., Karakasiliοtis, I., Bouros, D. E., & Steiropoulos, P. (2021) · Biomedicines · doi:10.3390/biomedicines9040442 · Cited by 22
Crosstalk between Body Microbiota and the Regulation of Immunity
Rojas, C., Gálvez‐Jirón, F., Solminihac, J. D., Padilla, C., Cárcamo, I., Villalón, N., Kurte, M., & Pino‐Lagos, K. (2022) · Journal of Immunology Research · doi:10.1155/2022/6274265 · Cited by 19
“Still, lung microbiota presents less bacterial biomass compared to the lower gastrointestinal tract but exhibits considerable diversity [50].”
BackgroundMicrobial Biomarkers for Lung Cancer: Current Understandings and Limitations
Huang, J., & Huang, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247298 · Cited by 23
“In healthy lungs, such lung microbiomes are in low abundance, with a much lower microbial biomass than other body sites [16].”
BackgroundUrinary microbiome in uncomplicated and interstitial cystitis: is there any similarity?
Yıldırım, S., Shoskes, D. A., Kulkarni, S., & Laguna, M. P. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03099-x · Cited by 19
Diversity of Microbial Signatures in Asthmatic Airways
Alamri, A. M. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s304339 · Cited by 17
“cies using special collection techniques, such as bronchoscopy, to collect BAL.(38) The microbiota of the”
BackgroundMethodInfluentialSecondo, L. E., Sagona, J. A., Calderon, L., Wang, Z., Plotnik, D., Senick, J., Allacci, M. S., Wener, R. E., Andrews, C. J., & Mainelis, G. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.0c05540 · Cited by 21
Meca, A.-D., Mititelu-Tarțău, L., Bogdán, M., Dijmărescu, L. A., Pelin, A.-M., & Foia, L. G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040569 · Cited by 20
Stankovic, M. M., Veljović, K., Popovic, N., Kojić, S., Manevski, S. D., Radojkovic, D. P., & Golić, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105547 · Cited by 17
“2 × 103 per cm2, due to the generally inhospitable lung environment for bacterial growth, and are constantly renewed and replaced by immigration, microaspiration, and elimination [4,18].”
BackgroundFinnicum, C. T., Rahal, Z., Hassane, M., Treekitkarnmongkol, W., Sinjab, A. F., Morris, R., Liu, Y., Tang, E., Viet, S., Petersen, J. L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810930 · Cited by 16
An update on current and emerging drug treatments for idiopathic pulmonary fibrosis
Trachalaki, A., Sultana, N., & Wells, A. U. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2213436 · Cited by 15
Exploring the complex relationship between the lung microbiome and ventilator-associated pneumonia
Bustos, I. G., Martín‐Loeches, I., Acosta‐González, A., Chotirmall, S. H., Dickson, R. P., & Reyes, L. F. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2273424 · Cited by 19
“The lung microbiome and host immunity interactions are complex and fundamental to developing or progressing various respiratory diseases [24,83,86].”
BackgroundSelf-citationTian, L., Li, X., Guo, L., Huang, L., Wu, X., & Gao, W. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216027 · Cited by 16
Krishnamoorthy, S., Coetzee, V., Kruger, J., Potgieter, H., & Buys, E. M. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.11.029 · Cited by 16
Mapping bacterial diversity and metabolic functionality of the human respiratory tract microbiome
Mancabelli, L., Milani, C., Fontana, F., Lugli, G. A., Tarracchini, C., Turroni, F., van Sinderen, D., & Ventura, M. (2022) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2051336 · Cited by 14
“However, in contrast to the gastrointestinal tract, which represents the most thoroughly investigated organ-microbiota niche, the human respiratory tract remains relatively poorly investigated [90,91].”
BackgroundThe lung microbiome in patients with pneumocystosis
Kehrmann, J., Veckollari, B., Schmidt, D., Schildgen, O., Schildgen, O., Wagner, N., Zeschnigk, M., Klein‐Hitpaß, L., Witzke, O., Buer, J., et al. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0512-5 · Cited by 19
“Furthermore, it is widely accepted that microbiological communities are a major regulator of the immune system and that alterations in the lung and/or gut microbiota may allow exacerbations of existing chronic lung diseases and can trigger susceptibility to new infections [9].”
BackgroundMucosal-Associated Invariant T Cells in Tumors of Epithelial Origin
Zumwalde, N. A., & Gumperz, J. E. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35723-8_5 · Cited by 16
The lung microbiome in interstitial lung disease
Mikhail, S. G., & O’Dwyer, D. N. (2025) · Breathe · doi:10.1183/20734735.0167-2024 · Cited by 17
“The lung microbiome is a unique low-biomass community that exists in a postulated dynamic state [26].”
Self-citationA review and roadmap of the skin, lung and gut microbiota in systemic sclerosis
Teaw, S., Hinchcliff, M., & Cheng, M. (2021) · Rheumatology · doi:10.1093/rheumatology/keab262 · Cited by 15
Maina, J. N. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13000 · Cited by 18
Oral microbiota and respiratory diseases: advances and perspectives
Liu, X., Shi, F., Zeng, J., Bi, J., Mo, C., Chai, Y., Wu, B., & Xu, S. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00150-24 · Cited by 20
“However, microbiota reportedly contribute to its pathogenesis (197) by inducing inflammation (198).”
Toll-like receptors, environmental caging, and lung dysbiosis
Lipinski, J. H., Falkowski, N. R., Huffnagle, G. B., Erb‐Downward, J. R., Dickson, R. P., Moore, B. B., & O’Dwyer, D. N. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00002.2021 · Cited by 14
Self-citationElucidating cellular origins and TME dynamic evolution in NSCLC through multi-omics technologies
Chao, N. N., & Zhang, L. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189425 · Cited by 22
Recommendations for COPD management in Central and Eastern Europe
Valipour, A., Айсанов, З. Р., Avdeev, S. N., Koblížek, V., Kocan, I., Kopitović, I., Lupkovics, G., Man, M. A., Bukovskis, M., Tudorić, N., et al. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.2023498 · Cited by 13
Knudsen, K. S., Lehmann, S., Nielsen, R., Tangedal, S., Haaland, I., Hiemstra, P. S., & Eagan, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262082 · Cited by 15
Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies
Lérias, J. R., Paraschoudi, G., de Sousa, E., Martins, J. D., Condeço, C., Figueiredo, N., Carvalho, C. T., Dodoo, E., Castillo-Martín, M., López-Beltrán, A., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00362 · Cited by 14
“Dysbiosis of the lung microbiota is implicated in the development of autoimmune pathology (O’Dwyer et al., 2016), while immune activation of gut fungal microbiota-specific T cells can influence and alter immune responses in the lung (Bacher et al.”
BackgroundMicrobiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases
Magryś, A. (2021) · Polish Journal of Microbiology · doi:10.33073/pjm-2021-013 · Cited by 14
“Particular metabolites and toxins with immunoregulatory properties are released, and other permissive niches for other species to reside there are created (O’Dwyer et al. 2016; Toraldo end Conte 2019).”
BackgroundZhou, M., Liu, Y., Yin, X., Gong, J., & Li, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03440-z · Cited by 16
“Furthermore, lung-associated bacteria stimulate myeloid cells to produce IL-1β and IL-23 via MyD88-dependent pathways, activating γδ T cells and IL-17 production, which collectively promote tumor-proliferative inflammation [59, 60].”
Advances in the design of new types of inhaled medicines
Czechtizky, W., Su, W., Ripa, L., Schießer, S., Höijer, A., & Cox, R. J. (2022) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2022.04.001 · Cited by 13
Panumasvivat, J., Pratchayasakul, W., Sapbamrer, R., Chattipakorn, N., & Chattipakorn, S. C. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03452-0 · Cited by 15
“Furthermore, the pathogenesis of each respiratory disease, such as architectural distortion of the lung in COPD, local immunologic response in the lungs, antibiotic use, biofilm formation, osmotic changes, and thickened mucus in cystic fibrosis, also influenced the respiratory microbiome and led to alterations in the…”
BackgroundNasal Microbiota Modifies the Effects of Particulate Air Pollution on Plasma Extracellular Vesicles
Mariani, J., Favero, C., Carugno, M., Pergoli, L., Ferrari, L., Bonzini, M., Cattaneo, A., Pesatori, A. C., & Bollati, V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020611 · Cited by 13
“These changes lead to modifications of the indigenous bacterial community, perturbing the structure and the relationships existing between the different species of the microbiota and potentially modifying the equilibrium between the bacteria community and the host, which often leads to unhealthy conditions [30,31].”
BackgroundRespiratory viruses in mechanically ventilated patients: a pilot study
Nazareth, R., Chasqueira, M. D. J., Rodrigues, M.-L., Paulino, M. C., Conceição, C., Lêdo, L. S. A., Segura, Ú., Santos, M., Messias, A. M., Póvoa, P. M. S. R., et al. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-1082-5 · Cited by 12
“Respiratory culture-based protocols sought only to identify clinically significant pathogens [8] .”
Background
Metadata
- Authors
- O’Dwyer, D. N., Dickson, R. P., & Moore, B. B.
- Affiliations
- Michigan Medicine (US)
- University of Michigan (US)
- Corresponding author
- Moore, Bethany B
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06
- Volume
- 196
- Issue
- 12
- Pages
- 4839-4847
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4894335
- OpenAlex
- W2413745624
- Cited by
- 362
- References
- 134
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 31 · 2023: 39 · 2022: 50 · 2021: 55 · 2020: 65 · 2019: 34 · 2018: 26 · 2017: 15 · 2016: 4
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000433)
- National Heart, Lung, and Blood Institute (R01HL115618, L30 HL120241, R01HL119682, K23HL130641, R01HL127805, T32HL007749)
- National Institute of Allergy and Infectious Diseases (R01AI117229)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- lung microbiome, chronic lung disease, dysbiosis, lung immunity, disease exacerbation, host-microbe interactions, bacterial diversity, pathogenesis
- MeSH terms
- Bacteria, Chronic Disease, Homeostasis, Humans, Lung, Lung Diseases, Disease Progression, Host-Pathogen Interactions, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.